[1]
M. Al-Temimi, H. et al. 2017. Evaluation of Metformin + Sitagliptin versus Metformin + Glibenclamide on Glycemic Control in Iraqis Type 2 Diabetic Patients. Iraqi Journal of Pharmaceutical Sciences. 21, 2 (Mar. 2017), 69–76. DOI:https://doi.org/10.31351/vol21iss2pp69-76.